nodes	percent_of_prediction	percent_of_DWPC	metapath
Glycine—Fluid overload—Carboplatin—ovarian cancer	0.0146	0.068	CcSEcCtD
Glycine—Diuresis—Vinorelbine—ovarian cancer	0.0115	0.0534	CcSEcCtD
Glycine—Electrolyte imbalance—Vinorelbine—ovarian cancer	0.00851	0.0396	CcSEcCtD
Glycine—ALAS2—decidua—ovarian cancer	0.00829	0.0175	CbGeAlD
Glycine—SHMT1—Vincristine—Vinorelbine—ovarian cancer	0.00762	0.554	CbGdCrCtD
Glycine—PIPOX—myometrium—ovarian cancer	0.0075	0.0158	CbGeAlD
Glycine—GLYATL2—bone marrow—ovarian cancer	0.00735	0.0155	CbGeAlD
Glycine—GPR18—endometrium—ovarian cancer	0.00728	0.0153	CbGeAlD
Glycine—GCAT—myometrium—ovarian cancer	0.00728	0.0153	CbGeAlD
Glycine—GPR18—gonad—ovarian cancer	0.00676	0.0142	CbGeAlD
Glycine—ALAS2—female reproductive system—ovarian cancer	0.00652	0.0137	CbGeAlD
Glycine—ALAS1—myometrium—ovarian cancer	0.00638	0.0134	CbGeAlD
Glycine—ALAS2—bone marrow—ovarian cancer	0.00616	0.013	CbGeAlD
Glycine—SHMT1—Vinblastine—Vinorelbine—ovarian cancer	0.00613	0.446	CbGdCrCtD
Glycine—GPR18—female reproductive system—ovarian cancer	0.00603	0.0127	CbGeAlD
Glycine—GLDC—decidua—ovarian cancer	0.00596	0.0125	CbGeAlD
Glycine—Lung disorder—Topotecan—ovarian cancer	0.00587	0.0274	CcSEcCtD
Glycine—PIPOX—uterine cervix—ovarian cancer	0.00584	0.0123	CbGeAlD
Glycine—GARS—myometrium—ovarian cancer	0.00581	0.0122	CbGeAlD
Glycine—SLC32A1—testis—ovarian cancer	0.0058	0.0122	CbGeAlD
Glycine—Electrolyte imbalance—Paclitaxel—ovarian cancer	0.00572	0.0267	CcSEcCtD
Glycine—GPR18—bone marrow—ovarian cancer	0.0057	0.012	CbGeAlD
Glycine—GLDC—endometrium—ovarian cancer	0.00566	0.0119	CbGeAlD
Glycine—GCSH—female reproductive system—ovarian cancer	0.00565	0.0119	CbGeAlD
Glycine—AGXT2—gonad—ovarian cancer	0.00561	0.0118	CbGeAlD
Glycine—SLC6A9—testis—ovarian cancer	0.0056	0.0118	CbGeAlD
Glycine—GRIN3B—testis—ovarian cancer	0.0056	0.0118	CbGeAlD
Glycine—GARS—embryo—ovarian cancer	0.00559	0.0118	CbGeAlD
Glycine—PIPOX—decidua—ovarian cancer	0.00556	0.0117	CbGeAlD
Glycine—GPR18—vagina—ovarian cancer	0.00546	0.0115	CbGeAlD
Glycine—PIPOX—endometrium—ovarian cancer	0.00528	0.0111	CbGeAlD
Glycine—ALAS2—testis—ovarian cancer	0.00526	0.0111	CbGeAlD
Glycine—Vertigo—Altretamine—ovarian cancer	0.00516	0.024	CcSEcCtD
Glycine—GCSH—female gonad—ovarian cancer	0.00514	0.0108	CbGeAlD
Glycine—GCAT—endometrium—ovarian cancer	0.00512	0.0108	CbGeAlD
Glycine—SHMT2—myometrium—ovarian cancer	0.00505	0.0106	CbGeAlD
Glycine—Lung disorder—Vinorelbine—ovarian cancer	0.00502	0.0234	CcSEcCtD
Glycine—AGXT2—female reproductive system—ovarian cancer	0.00501	0.0106	CbGeAlD
Glycine—Convulsion—Altretamine—ovarian cancer	0.00497	0.0232	CcSEcCtD
Glycine—ALAS1—uterine cervix—ovarian cancer	0.00496	0.0104	CbGeAlD
Glycine—GNMT—female reproductive system—ovarian cancer	0.00494	0.0104	CbGeAlD
Glycine—GPR18—testis—ovarian cancer	0.00487	0.0103	CbGeAlD
Glycine—ALAS1—decidua—ovarian cancer	0.00473	0.00996	CbGeAlD
Glycine—GLDC—female reproductive system—ovarian cancer	0.00468	0.00986	CbGeAlD
Glycine—GCSH—testis—ovarian cancer	0.00456	0.00961	CbGeAlD
Glycine—GARS—uterine cervix—ovarian cancer	0.00452	0.00952	CbGeAlD
Glycine—ALAS1—endometrium—ovarian cancer	0.00449	0.00945	CbGeAlD
Glycine—GARS—decidua—ovarian cancer	0.00431	0.00907	CbGeAlD
Glycine—GATM—uterine cervix—ovarian cancer	0.00429	0.00903	CbGeAlD
Glycine—GLDC—vagina—ovarian cancer	0.00424	0.00892	CbGeAlD
Glycine—ALAS1—uterus—ovarian cancer	0.00414	0.00871	CbGeAlD
Glycine—GATM—decidua—ovarian cancer	0.00409	0.00861	CbGeAlD
Glycine—GARS—endometrium—ovarian cancer	0.00409	0.00861	CbGeAlD
Glycine—SLC6A9—lymph node—ovarian cancer	0.00406	0.00854	CbGeAlD
Glycine—AGXT2—testis—ovarian cancer	0.00405	0.00852	CbGeAlD
Glycine—GCAT—bone marrow—ovarian cancer	0.00401	0.00843	CbGeAlD
Glycine—PIPOX—female gonad—ovarian cancer	0.00398	0.00838	CbGeAlD
Glycine—PIPOX—vagina—ovarian cancer	0.00396	0.00833	CbGeAlD
Glycine—SHMT2—uterine cervix—ovarian cancer	0.00393	0.00828	CbGeAlD
Glycine—GCAT—female gonad—ovarian cancer	0.00386	0.00813	CbGeAlD
Glycine—GCAT—vagina—ovarian cancer	0.00384	0.00808	CbGeAlD
Glycine—GARS—gonad—ovarian cancer	0.00379	0.00798	CbGeAlD
Glycine—GLDC—testis—ovarian cancer	0.00378	0.00796	CbGeAlD
Glycine—GARS—uterus—ovarian cancer	0.00377	0.00793	CbGeAlD
Glycine—SHMT2—decidua—ovarian cancer	0.00375	0.00789	CbGeAlD
Glycine—Encephalopathy—Paclitaxel—ovarian cancer	0.00372	0.0174	CcSEcCtD
Glycine—ALAS1—female reproductive system—ovarian cancer	0.00372	0.00783	CbGeAlD
Glycine—GLRB—uterine cervix—ovarian cancer	0.00369	0.00776	CbGeAlD
Glycine—GATM—gonad—ovarian cancer	0.0036	0.00758	CbGeAlD
Glycine—SHMT1—uterine cervix—ovarian cancer	0.00358	0.00754	CbGeAlD
Glycine—GATM—uterus—ovarian cancer	0.00358	0.00753	CbGeAlD
Glycine—SHMT2—endometrium—ovarian cancer	0.00356	0.00749	CbGeAlD
Glycine—PIPOX—testis—ovarian cancer	0.00353	0.00743	CbGeAlD
Glycine—GPR18—lymph node—ovarian cancer	0.00353	0.00743	CbGeAlD
Glycine—ALAS1—bone marrow—ovarian cancer	0.00351	0.00739	CbGeAlD
Glycine—GSS—myometrium—ovarian cancer	0.00345	0.00727	CbGeAlD
Glycine—GCAT—testis—ovarian cancer	0.00342	0.00721	CbGeAlD
Glycine—GARS—female reproductive system—ovarian cancer	0.00339	0.00713	CbGeAlD
Glycine—ALAS1—female gonad—ovarian cancer	0.00338	0.00712	CbGeAlD
Glycine—ALAS1—vagina—ovarian cancer	0.00336	0.00708	CbGeAlD
Glycine—GCSH—lymph node—ovarian cancer	0.00331	0.00696	CbGeAlD
Glycine—SHMT2—gonad—ovarian cancer	0.0033	0.00695	CbGeAlD
Glycine—SHMT2—uterus—ovarian cancer	0.00328	0.0069	CbGeAlD
Glycine—SHMT1—endometrium—ovarian cancer	0.00324	0.00682	CbGeAlD
Glycine—GATM—female reproductive system—ovarian cancer	0.00322	0.00677	CbGeAlD
Glycine—GARS—bone marrow—ovarian cancer	0.0032	0.00673	CbGeAlD
Glycine—Dizziness—Altretamine—ovarian cancer	0.0031	0.0144	CcSEcCtD
Glycine—GARS—female gonad—ovarian cancer	0.00308	0.00649	CbGeAlD
Glycine—GARS—vagina—ovarian cancer	0.00306	0.00645	CbGeAlD
Glycine—SHMT1—gonad—ovarian cancer	0.003	0.00632	CbGeAlD
Glycine—ALAS1—testis—ovarian cancer	0.003	0.00632	CbGeAlD
Glycine—Thrombophlebitis—Vinorelbine—ovarian cancer	0.00298	0.0139	CcSEcCtD
Glycine—Vomiting—Altretamine—ovarian cancer	0.00298	0.0139	CcSEcCtD
Glycine—Hyponatraemia—Melphalan—ovarian cancer	0.00297	0.0138	CcSEcCtD
Glycine—SHMT2—female reproductive system—ovarian cancer	0.00295	0.0062	CbGeAlD
Glycine—Polyuria—Vinorelbine—ovarian cancer	0.00294	0.0137	CcSEcCtD
Glycine—GATM—female gonad—ovarian cancer	0.00293	0.00616	CbGeAlD
Glycine—GATM—vagina—ovarian cancer	0.00291	0.00612	CbGeAlD
Glycine—Nausea—Altretamine—ovarian cancer	0.00278	0.013	CcSEcCtD
Glycine—SHMT2—bone marrow—ovarian cancer	0.00278	0.00586	CbGeAlD
Glycine—Pain—Carboplatin—ovarian cancer	0.00277	0.0129	CcSEcCtD
Glycine—GLDC—lymph node—ovarian cancer	0.00274	0.00577	CbGeAlD
Glycine—GARS—testis—ovarian cancer	0.00273	0.00575	CbGeAlD
Glycine—GRIN2C—testis—ovarian cancer	0.00269	0.00566	CbGeAlD
Glycine—GSS—uterine cervix—ovarian cancer	0.00269	0.00566	CbGeAlD
Glycine—SHMT1—female reproductive system—ovarian cancer	0.00268	0.00565	CbGeAlD
Glycine—SHMT2—female gonad—ovarian cancer	0.00268	0.00564	CbGeAlD
Glycine—SHMT2—vagina—ovarian cancer	0.00266	0.00561	CbGeAlD
Glycine—GATM—testis—ovarian cancer	0.00259	0.00546	CbGeAlD
Glycine—Hyponatraemia—Vinorelbine—ovarian cancer	0.00259	0.0121	CcSEcCtD
Glycine—SLC36A1—gonad—ovarian cancer	0.00256	0.00539	CbGeAlD
Glycine—GSS—decidua—ovarian cancer	0.00256	0.00539	CbGeAlD
Glycine—SLC36A1—uterus—ovarian cancer	0.00255	0.00536	CbGeAlD
Glycine—SHMT1—bone marrow—ovarian cancer	0.00253	0.00533	CbGeAlD
Glycine—GLRB—vagina—ovarian cancer	0.0025	0.00526	CbGeAlD
Glycine—GCAT—lymph node—ovarian cancer	0.00248	0.00523	CbGeAlD
Glycine—SHMT1—female gonad—ovarian cancer	0.00244	0.00514	CbGeAlD
Glycine—GSS—endometrium—ovarian cancer	0.00243	0.00512	CbGeAlD
Glycine—SHMT1—vagina—ovarian cancer	0.00243	0.00511	CbGeAlD
Glycine—SHMT2—testis—ovarian cancer	0.00238	0.00501	CbGeAlD
Glycine—SLC36A1—female reproductive system—ovarian cancer	0.00229	0.00482	CbGeAlD
Glycine—GSS—gonad—ovarian cancer	0.00226	0.00475	CbGeAlD
Glycine—GSS—uterus—ovarian cancer	0.00224	0.00472	CbGeAlD
Glycine—ALAS1—lymph node—ovarian cancer	0.00218	0.00458	CbGeAlD
Glycine—Angina pectoris—Vinorelbine—ovarian cancer	0.00217	0.0101	CcSEcCtD
Glycine—SHMT1—testis—ovarian cancer	0.00216	0.00456	CbGeAlD
Glycine—SLC36A1—bone marrow—ovarian cancer	0.00216	0.00455	CbGeAlD
Glycine—Lightheadedness—Paclitaxel—ovarian cancer	0.00214	0.00997	CcSEcCtD
Glycine—Rhinitis—Topotecan—ovarian cancer	0.00209	0.00975	CcSEcCtD
Glycine—GRIN2A—vagina—ovarian cancer	0.00208	0.00438	CbGeAlD
Glycine—SLC36A1—female gonad—ovarian cancer	0.00208	0.00438	CbGeAlD
Glycine—SLC36A1—vagina—ovarian cancer	0.00207	0.00436	CbGeAlD
Glycine—GSS—female reproductive system—ovarian cancer	0.00201	0.00424	CbGeAlD
Glycine—Thrombophlebitis—Paclitaxel—ovarian cancer	0.00201	0.00934	CcSEcCtD
Glycine—SLC16A10—epithelium—ovarian cancer	0.00199	0.00418	CbGeAlD
Glycine—GARS—lymph node—ovarian cancer	0.00198	0.00417	CbGeAlD
Glycine—Polyuria—Paclitaxel—ovarian cancer	0.00198	0.00921	CcSEcCtD
Glycine—Lung disorder—Epirubicin—ovarian cancer	0.00193	0.009	CcSEcCtD
Glycine—GSS—bone marrow—ovarian cancer	0.0019	0.004	CbGeAlD
Glycine—GATM—lymph node—ovarian cancer	0.00188	0.00396	CbGeAlD
Glycine—Chills—Topotecan—ovarian cancer	0.00187	0.00872	CcSEcCtD
Glycine—GRIN2A—testis—ovarian cancer	0.00186	0.00391	CbGeAlD
Glycine—SLC36A1—testis—ovarian cancer	0.00185	0.00389	CbGeAlD
Glycine—GSS—female gonad—ovarian cancer	0.00183	0.00386	CbGeAlD
Glycine—Visual disturbance—Paclitaxel—ovarian cancer	0.00183	0.00853	CcSEcCtD
Glycine—GSS—vagina—ovarian cancer	0.00182	0.00384	CbGeAlD
Glycine—Lightheadedness—Docetaxel—ovarian cancer	0.00181	0.00845	CcSEcCtD
Glycine—Lung disorder—Doxorubicin—ovarian cancer	0.00179	0.00833	CcSEcCtD
Glycine—Convulsion—Chlorambucil—ovarian cancer	0.00177	0.00824	CcSEcCtD
Glycine—Back pain—Topotecan—ovarian cancer	0.00176	0.00819	CcSEcCtD
Glycine—Hyponatraemia—Paclitaxel—ovarian cancer	0.00174	0.00812	CcSEcCtD
Glycine—SHMT2—lymph node—ovarian cancer	0.00172	0.00363	CbGeAlD
Glycine—Thrombophlebitis—Docetaxel—ovarian cancer	0.0017	0.00792	CcSEcCtD
Glycine—SLC16A10—gonad—ovarian cancer	0.00165	0.00348	CbGeAlD
Glycine—GSS—testis—ovarian cancer	0.00163	0.00342	CbGeAlD
Glycine—GLRB—lymph node—ovarian cancer	0.00162	0.0034	CbGeAlD
Glycine—Dehydration—Paclitaxel—ovarian cancer	0.00161	0.00752	CcSEcCtD
Glycine—SHMT1—lymph node—ovarian cancer	0.00157	0.0033	CbGeAlD
Glycine—Cardiovascular disorder—Epirubicin—ovarian cancer	0.00156	0.00725	CcSEcCtD
Glycine—Visual disturbance—Docetaxel—ovarian cancer	0.00155	0.00723	CcSEcCtD
Glycine—Convulsion—Melphalan—ovarian cancer	0.00154	0.00718	CcSEcCtD
Glycine—Back pain—Vinorelbine—ovarian cancer	0.0015	0.007	CcSEcCtD
Glycine—Hyponatraemia—Docetaxel—ovarian cancer	0.00148	0.00688	CcSEcCtD
Glycine—SLC16A10—female reproductive system—ovarian cancer	0.00148	0.00311	CbGeAlD
Glycine—Oedema—Melphalan—ovarian cancer	0.00145	0.00676	CcSEcCtD
Glycine—Cardiovascular disorder—Doxorubicin—ovarian cancer	0.00144	0.00671	CcSEcCtD
Glycine—Pain—Chlorambucil—ovarian cancer	0.00142	0.00663	CcSEcCtD
Glycine—Tachycardia—Melphalan—ovarian cancer	0.00142	0.0066	CcSEcCtD
Glycine—Vertigo—Vinorelbine—ovarian cancer	0.0014	0.0065	CcSEcCtD
Glycine—Dehydration—Docetaxel—ovarian cancer	0.00137	0.00637	CcSEcCtD
Glycine—Hypotension—Melphalan—ovarian cancer	0.00136	0.00632	CcSEcCtD
Glycine—SLC36A1—lymph node—ovarian cancer	0.00134	0.00282	CbGeAlD
Glycine—SLC16A10—vagina—ovarian cancer	0.00133	0.00281	CbGeAlD
Glycine—Salivary hypersecretion—Epirubicin—ovarian cancer	0.00133	0.00618	CcSEcCtD
Glycine—Urticaria—Chlorambucil—ovarian cancer	0.00132	0.00616	CcSEcCtD
Glycine—Pain—Topotecan—ovarian cancer	0.00127	0.00591	CcSEcCtD
Glycine—Coma—Epirubicin—ovarian cancer	0.00125	0.00582	CcSEcCtD
Glycine—Pain—Melphalan—ovarian cancer	0.00124	0.00578	CcSEcCtD
Glycine—Angina pectoris—Docetaxel—ovarian cancer	0.00124	0.00577	CcSEcCtD
Glycine—Tachycardia—Vinorelbine—ovarian cancer	0.00124	0.00577	CcSEcCtD
Glycine—Salivary hypersecretion—Doxorubicin—ovarian cancer	0.00123	0.00572	CcSEcCtD
Glycine—Hypersensitivity—Chlorambucil—ovarian cancer	0.00123	0.00572	CcSEcCtD
Glycine—Rhinitis—Paclitaxel—ovarian cancer	0.0012	0.00561	CcSEcCtD
Glycine—SLC16A10—testis—ovarian cancer	0.00119	0.00251	CbGeAlD
Glycine—Hypotension—Vinorelbine—ovarian cancer	0.00119	0.00552	CcSEcCtD
Glycine—GSS—lymph node—ovarian cancer	0.00118	0.00248	CbGeAlD
Glycine—Urticaria—Topotecan—ovarian cancer	0.00118	0.00549	CcSEcCtD
Glycine—Visual impairment—Paclitaxel—ovarian cancer	0.00116	0.00539	CcSEcCtD
Glycine—Coma—Doxorubicin—ovarian cancer	0.00116	0.00538	CcSEcCtD
Glycine—Urticaria—Melphalan—ovarian cancer	0.00115	0.00537	CcSEcCtD
Glycine—Thrombophlebitis—Epirubicin—ovarian cancer	0.00115	0.00534	CcSEcCtD
Glycine—Diarrhoea—Chlorambucil—ovarian cancer	0.00114	0.00531	CcSEcCtD
Glycine—Hypersensitivity—Topotecan—ovarian cancer	0.00109	0.00509	CcSEcCtD
Glycine—Pain—Vinorelbine—ovarian cancer	0.00108	0.00505	CcSEcCtD
Glycine—Chills—Paclitaxel—ovarian cancer	0.00108	0.00502	CcSEcCtD
Glycine—Hypersensitivity—Melphalan—ovarian cancer	0.00107	0.00498	CcSEcCtD
Glycine—Thrombophlebitis—Doxorubicin—ovarian cancer	0.00106	0.00494	CcSEcCtD
Glycine—Vomiting—Chlorambucil—ovarian cancer	0.00106	0.00493	CcSEcCtD
Glycine—Rhinitis—Docetaxel—ovarian cancer	0.00102	0.00475	CcSEcCtD
Glycine—Diarrhoea—Topotecan—ovarian cancer	0.00101	0.00473	CcSEcCtD
Glycine—Back pain—Paclitaxel—ovarian cancer	0.00101	0.00471	CcSEcCtD
Glycine—Urticaria—Vinorelbine—ovarian cancer	0.00101	0.00469	CcSEcCtD
Glycine—Hyponatraemia—Epirubicin—ovarian cancer	0.000996	0.00464	CcSEcCtD
Glycine—Diarrhoea—Melphalan—ovarian cancer	0.000993	0.00463	CcSEcCtD
Glycine—Nausea—Chlorambucil—ovarian cancer	0.000989	0.00461	CcSEcCtD
Glycine—Vision blurred—Paclitaxel—ovarian cancer	0.000985	0.00459	CcSEcCtD
Glycine—Visual impairment—Docetaxel—ovarian cancer	0.000981	0.00457	CcSEcCtD
Glycine—Dizziness—Topotecan—ovarian cancer	0.00098	0.00457	CcSEcCtD
Glycine—Vomiting—Topotecan—ovarian cancer	0.000943	0.00439	CcSEcCtD
Glycine—Vertigo—Paclitaxel—ovarian cancer	0.000939	0.00438	CcSEcCtD
Glycine—Hypersensitivity—Vinorelbine—ovarian cancer	0.000934	0.00435	CcSEcCtD
Glycine—Vomiting—Melphalan—ovarian cancer	0.000923	0.0043	CcSEcCtD
Glycine—Dehydration—Epirubicin—ovarian cancer	0.000923	0.0043	CcSEcCtD
Glycine—Hyponatraemia—Doxorubicin—ovarian cancer	0.000922	0.00429	CcSEcCtD
Glycine—Chills—Docetaxel—ovarian cancer	0.000913	0.00425	CcSEcCtD
Glycine—Convulsion—Paclitaxel—ovarian cancer	0.000906	0.00422	CcSEcCtD
Glycine—Nausea—Topotecan—ovarian cancer	0.000881	0.0041	CcSEcCtD
Glycine—Diarrhoea—Vinorelbine—ovarian cancer	0.000868	0.00404	CcSEcCtD
Glycine—SLC16A10—lymph node—ovarian cancer	0.000863	0.00182	CbGeAlD
Glycine—Nausea—Melphalan—ovarian cancer	0.000862	0.00402	CcSEcCtD
Glycine—Back pain—Docetaxel—ovarian cancer	0.000857	0.00399	CcSEcCtD
Glycine—Dehydration—Doxorubicin—ovarian cancer	0.000854	0.00398	CcSEcCtD
Glycine—Oedema—Paclitaxel—ovarian cancer	0.000853	0.00397	CcSEcCtD
Glycine—Dizziness—Vinorelbine—ovarian cancer	0.000839	0.00391	CcSEcCtD
Glycine—Angina pectoris—Epirubicin—ovarian cancer	0.000835	0.00389	CcSEcCtD
Glycine—Tachycardia—Paclitaxel—ovarian cancer	0.000833	0.00388	CcSEcCtD
Glycine—Vomiting—Vinorelbine—ovarian cancer	0.000806	0.00376	CcSEcCtD
Glycine—Hypotension—Paclitaxel—ovarian cancer	0.000797	0.00371	CcSEcCtD
Glycine—Angina pectoris—Doxorubicin—ovarian cancer	0.000773	0.0036	CcSEcCtD
Glycine—Convulsion—Docetaxel—ovarian cancer	0.000768	0.00358	CcSEcCtD
Glycine—Nausea—Vinorelbine—ovarian cancer	0.000753	0.00351	CcSEcCtD
Glycine—Pain—Paclitaxel—ovarian cancer	0.000729	0.0034	CcSEcCtD
Glycine—Oedema—Docetaxel—ovarian cancer	0.000723	0.00337	CcSEcCtD
Glycine—Tachycardia—Docetaxel—ovarian cancer	0.000706	0.00329	CcSEcCtD
Glycine—Rhinitis—Epirubicin—ovarian cancer	0.000688	0.00321	CcSEcCtD
Glycine—Urticaria—Paclitaxel—ovarian cancer	0.000678	0.00316	CcSEcCtD
Glycine—Hypotension—Docetaxel—ovarian cancer	0.000676	0.00315	CcSEcCtD
Glycine—Visual impairment—Epirubicin—ovarian cancer	0.000662	0.00308	CcSEcCtD
Glycine—Rhinitis—Doxorubicin—ovarian cancer	0.000637	0.00297	CcSEcCtD
Glycine—Hypersensitivity—Paclitaxel—ovarian cancer	0.000629	0.00293	CcSEcCtD
Glycine—Pain—Docetaxel—ovarian cancer	0.000618	0.00288	CcSEcCtD
Glycine—Chills—Epirubicin—ovarian cancer	0.000616	0.00287	CcSEcCtD
Glycine—Visual impairment—Doxorubicin—ovarian cancer	0.000612	0.00285	CcSEcCtD
Glycine—Diarrhoea—Paclitaxel—ovarian cancer	0.000584	0.00272	CcSEcCtD
Glycine—Back pain—Epirubicin—ovarian cancer	0.000578	0.00269	CcSEcCtD
Glycine—Chills—Doxorubicin—ovarian cancer	0.00057	0.00266	CcSEcCtD
Glycine—Dizziness—Paclitaxel—ovarian cancer	0.000564	0.00263	CcSEcCtD
Glycine—Vision blurred—Epirubicin—ovarian cancer	0.000563	0.00262	CcSEcCtD
Glycine—Vomiting—Paclitaxel—ovarian cancer	0.000542	0.00253	CcSEcCtD
Glycine—Vertigo—Epirubicin—ovarian cancer	0.000537	0.0025	CcSEcCtD
Glycine—Back pain—Doxorubicin—ovarian cancer	0.000535	0.00249	CcSEcCtD
Glycine—Hypersensitivity—Docetaxel—ovarian cancer	0.000533	0.00248	CcSEcCtD
Glycine—Vision blurred—Doxorubicin—ovarian cancer	0.000521	0.00243	CcSEcCtD
Glycine—Convulsion—Epirubicin—ovarian cancer	0.000518	0.00241	CcSEcCtD
Glycine—Nausea—Paclitaxel—ovarian cancer	0.000507	0.00236	CcSEcCtD
Glycine—Vertigo—Doxorubicin—ovarian cancer	0.000497	0.00231	CcSEcCtD
Glycine—Diarrhoea—Docetaxel—ovarian cancer	0.000495	0.0023	CcSEcCtD
Glycine—Oedema—Epirubicin—ovarian cancer	0.000488	0.00227	CcSEcCtD
Glycine—Convulsion—Doxorubicin—ovarian cancer	0.000479	0.00223	CcSEcCtD
Glycine—Dizziness—Docetaxel—ovarian cancer	0.000478	0.00223	CcSEcCtD
Glycine—Tachycardia—Epirubicin—ovarian cancer	0.000476	0.00222	CcSEcCtD
Glycine—Vomiting—Docetaxel—ovarian cancer	0.00046	0.00214	CcSEcCtD
Glycine—Hypotension—Epirubicin—ovarian cancer	0.000456	0.00212	CcSEcCtD
Glycine—Oedema—Doxorubicin—ovarian cancer	0.000451	0.0021	CcSEcCtD
Glycine—Tachycardia—Doxorubicin—ovarian cancer	0.00044	0.00205	CcSEcCtD
Glycine—Nausea—Docetaxel—ovarian cancer	0.000429	0.002	CcSEcCtD
Glycine—Hypotension—Doxorubicin—ovarian cancer	0.000422	0.00196	CcSEcCtD
Glycine—Pain—Epirubicin—ovarian cancer	0.000417	0.00194	CcSEcCtD
Glycine—Urticaria—Epirubicin—ovarian cancer	0.000387	0.00181	CcSEcCtD
Glycine—Pain—Doxorubicin—ovarian cancer	0.000386	0.0018	CcSEcCtD
Glycine—Hypersensitivity—Epirubicin—ovarian cancer	0.000359	0.00167	CcSEcCtD
Glycine—Urticaria—Doxorubicin—ovarian cancer	0.000358	0.00167	CcSEcCtD
Glycine—Diarrhoea—Epirubicin—ovarian cancer	0.000334	0.00155	CcSEcCtD
Glycine—Hypersensitivity—Doxorubicin—ovarian cancer	0.000332	0.00155	CcSEcCtD
Glycine—Dizziness—Epirubicin—ovarian cancer	0.000323	0.0015	CcSEcCtD
Glycine—Vomiting—Epirubicin—ovarian cancer	0.00031	0.00144	CcSEcCtD
Glycine—Diarrhoea—Doxorubicin—ovarian cancer	0.000309	0.00144	CcSEcCtD
Glycine—Dizziness—Doxorubicin—ovarian cancer	0.000298	0.00139	CcSEcCtD
Glycine—Nausea—Epirubicin—ovarian cancer	0.00029	0.00135	CcSEcCtD
Glycine—Vomiting—Doxorubicin—ovarian cancer	0.000287	0.00134	CcSEcCtD
Glycine—Nausea—Doxorubicin—ovarian cancer	0.000268	0.00125	CcSEcCtD
Glycine—GRIN2A—Alzheimers Disease—TP53—ovarian cancer	0.000236	0.000796	CbGpPWpGaD
Glycine—BAAT—Metabolism—SLC5A5—ovarian cancer	0.000236	0.000794	CbGpPWpGaD
Glycine—GRIN2C—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—ovarian cancer	0.000233	0.000786	CbGpPWpGaD
Glycine—GATM—Metabolism—CYP1B1—ovarian cancer	0.000229	0.000771	CbGpPWpGaD
Glycine—GLYAT—Metabolism—CYP1B1—ovarian cancer	0.000229	0.000771	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—CYP1B1—ovarian cancer	0.000229	0.000771	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—CYP1B1—ovarian cancer	0.000229	0.000771	CbGpPWpGaD
Glycine—BAAT—Metabolism—SLC2A1—ovarian cancer	0.000228	0.000767	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—PGR—ovarian cancer	0.000225	0.000758	CbGpPWpGaD
Glycine—BAAT—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	0.000223	0.000751	CbGpPWpGaD
Glycine—AGXT2—Metabolism—YAP1—ovarian cancer	0.000223	0.000751	CbGpPWpGaD
Glycine—SLC32A1—Neuronal System—HRAS—ovarian cancer	0.000222	0.000749	CbGpPWpGaD
Glycine—ALAS1—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	0.000221	0.000744	CbGpPWpGaD
Glycine—SLC36A1—Transmembrane transport of small molecules—ABCB1—ovarian cancer	0.00022	0.000743	CbGpPWpGaD
Glycine—BAAT—Metabolism—CYP1B1—ovarian cancer	0.000218	0.000736	CbGpPWpGaD
Glycine—AGXT—Metabolism—FASN—ovarian cancer	0.000214	0.00072	CbGpPWpGaD
Glycine—SHMT1—Disease—XIAP—ovarian cancer	0.000212	0.000716	CbGpPWpGaD
Glycine—GPR18—GPCR downstream signaling—PIK3CG—ovarian cancer	0.000212	0.000713	CbGpPWpGaD
Glycine—AGXT—Metabolism—SLC5A5—ovarian cancer	0.00021	0.000708	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—PARP1—ovarian cancer	0.000209	0.000705	CbGpPWpGaD
Glycine—SHMT1—Disease—SMARCA4—ovarian cancer	0.000207	0.000698	CbGpPWpGaD
Glycine—ALAS1—Metabolism—FASN—ovarian cancer	0.000207	0.000697	CbGpPWpGaD
Glycine—ALAS1—Metabolism—SLC5A5—ovarian cancer	0.000203	0.000686	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—PPP2R1A—ovarian cancer	0.000203	0.000684	CbGpPWpGaD
Glycine—GATM—Metabolism—PPP2R1A—ovarian cancer	0.000203	0.000684	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—PPP2R1A—ovarian cancer	0.000203	0.000684	CbGpPWpGaD
Glycine—GLYAT—Metabolism—PPP2R1A—ovarian cancer	0.000203	0.000684	CbGpPWpGaD
Glycine—AGXT—Metabolism—SLC2A1—ovarian cancer	0.000203	0.000684	CbGpPWpGaD
Glycine—SHMT1—Disease—EREG—ovarian cancer	0.000202	0.000681	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—IL6ST—ovarian cancer	0.0002	0.000674	CbGpPWpGaD
Glycine—ALAS2—Metabolism—CAV1—ovarian cancer	0.000197	0.000663	CbGpPWpGaD
Glycine—ALAS1—Metabolism—SLC2A1—ovarian cancer	0.000196	0.000662	CbGpPWpGaD
Glycine—AGXT—Metabolism—CYP1B1—ovarian cancer	0.000194	0.000656	CbGpPWpGaD
Glycine—BAAT—Metabolism—PPP2R1A—ovarian cancer	0.000193	0.000652	CbGpPWpGaD
Glycine—BAAT—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	0.000193	0.000649	CbGpPWpGaD
Glycine—ALAS1—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	0.000192	0.000649	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—PIK3CG—ovarian cancer	0.000192	0.000648	CbGpPWpGaD
Glycine—ALAS1—Metabolism—CYP1B1—ovarian cancer	0.000188	0.000635	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—ABCB1—ovarian cancer	0.000188	0.000635	CbGpPWpGaD
Glycine—GLYAT—Metabolism—ABCB1—ovarian cancer	0.000188	0.000635	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—ABCB1—ovarian cancer	0.000188	0.000635	CbGpPWpGaD
Glycine—GATM—Metabolism—ABCB1—ovarian cancer	0.000188	0.000635	CbGpPWpGaD
Glycine—GRIN2C—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	0.000187	0.000631	CbGpPWpGaD
Glycine—GPR18—GPCR downstream signaling—PIK3CD—ovarian cancer	0.000186	0.000627	CbGpPWpGaD
Glycine—GLYAT—Metabolism—TYMS—ovarian cancer	0.000185	0.000624	CbGpPWpGaD
Glycine—GATM—Metabolism—TYMS—ovarian cancer	0.000185	0.000624	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—TYMS—ovarian cancer	0.000185	0.000624	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—TYMS—ovarian cancer	0.000185	0.000624	CbGpPWpGaD
Glycine—AGXT2—Metabolism—FASN—ovarian cancer	0.000182	0.000612	CbGpPWpGaD
Glycine—SHMT1—Metabolism—YAP1—ovarian cancer	0.000182	0.000612	CbGpPWpGaD
Glycine—BAAT—Metabolism—ABCB1—ovarian cancer	0.00018	0.000606	CbGpPWpGaD
Glycine—ALAS2—Metabolism—PIK3CG—ovarian cancer	0.000179	0.000604	CbGpPWpGaD
Glycine—AGXT2—Metabolism—SLC5A5—ovarian cancer	0.000179	0.000602	CbGpPWpGaD
Glycine—GRIN2A—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—ovarian cancer	0.000178	0.0006	CbGpPWpGaD
Glycine—GSS—Metabolism—YAP1—ovarian cancer	0.000177	0.000596	CbGpPWpGaD
Glycine—SHMT1—Disease—FASN—ovarian cancer	0.000177	0.000596	CbGpPWpGaD
Glycine—BAAT—Metabolism—TYMS—ovarian cancer	0.000176	0.000595	CbGpPWpGaD
Glycine—SHMT1—Disease—PARP1—ovarian cancer	0.000176	0.000593	CbGpPWpGaD
Glycine—SLC16A10—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	0.000176	0.000592	CbGpPWpGaD
Glycine—GRIN2C—Transmission across Chemical Synapses—MAPK1—ovarian cancer	0.000175	0.000591	CbGpPWpGaD
Glycine—AGXT2—Metabolism—SLC2A1—ovarian cancer	0.000172	0.000581	CbGpPWpGaD
Glycine—AGXT—Metabolism—PPP2R1A—ovarian cancer	0.000172	0.000581	CbGpPWpGaD
Glycine—SLC16A10—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	0.00017	0.000572	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—PPP2R1A—ovarian cancer	0.00017	0.000572	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—PIK3CD—ovarian cancer	0.000169	0.00057	CbGpPWpGaD
Glycine—SHMT1—Disease—SLC2A1—ovarian cancer	0.000168	0.000566	CbGpPWpGaD
Glycine—ALAS1—Metabolism—PPP2R1A—ovarian cancer	0.000167	0.000563	CbGpPWpGaD
Glycine—ALAS1—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	0.000166	0.00056	CbGpPWpGaD
Glycine—AGXT2—Metabolism—CYP1B1—ovarian cancer	0.000165	0.000557	CbGpPWpGaD
Glycine—GPR18—GPCR downstream signaling—PIK3CB—ovarian cancer	0.000162	0.000547	CbGpPWpGaD
Glycine—AGXT—Metabolism—ABCB1—ovarian cancer	0.00016	0.00054	CbGpPWpGaD
Glycine—ALAS2—Metabolism—PIK3CD—ovarian cancer	0.000157	0.000531	CbGpPWpGaD
Glycine—AGXT—Metabolism—TYMS—ovarian cancer	0.000157	0.00053	CbGpPWpGaD
Glycine—GPR18—GPCR downstream signaling—CXCL8—ovarian cancer	0.000156	0.000525	CbGpPWpGaD
Glycine—ALAS1—Metabolism—ABCB1—ovarian cancer	0.000155	0.000523	CbGpPWpGaD
Glycine—ALAS1—Metabolism—TYMS—ovarian cancer	0.000152	0.000514	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—CAV1—ovarian cancer	0.000149	0.000503	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—CAV1—ovarian cancer	0.000149	0.000503	CbGpPWpGaD
Glycine—GLYAT—Metabolism—CAV1—ovarian cancer	0.000149	0.000503	CbGpPWpGaD
Glycine—GATM—Metabolism—CAV1—ovarian cancer	0.000149	0.000503	CbGpPWpGaD
Glycine—GPR18—GPCR downstream signaling—IL2—ovarian cancer	0.000149	0.000502	CbGpPWpGaD
Glycine—SHMT1—Metabolism—FASN—ovarian cancer	0.000148	0.000499	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—PIK3CB—ovarian cancer	0.000147	0.000496	CbGpPWpGaD
Glycine—AGXT2—Metabolism—PPP2R1A—ovarian cancer	0.000147	0.000494	CbGpPWpGaD
Glycine—SHMT1—Metabolism—SLC5A5—ovarian cancer	0.000146	0.000491	CbGpPWpGaD
Glycine—GSS—Metabolism—FASN—ovarian cancer	0.000144	0.000486	CbGpPWpGaD
Glycine—GRIN2A—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	0.000143	0.000482	CbGpPWpGaD
Glycine—SHMT1—Disease—PPP2R1A—ovarian cancer	0.000143	0.000481	CbGpPWpGaD
Glycine—BAAT—Metabolism—CAV1—ovarian cancer	0.000142	0.000479	CbGpPWpGaD
Glycine—GSS—Metabolism—SLC5A5—ovarian cancer	0.000142	0.000478	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—CXCL8—ovarian cancer	0.000141	0.000477	CbGpPWpGaD
Glycine—GRIN2C—Transmission across Chemical Synapses—HRAS—ovarian cancer	0.000141	0.000474	CbGpPWpGaD
Glycine—SHMT1—Metabolism—SLC2A1—ovarian cancer	0.000141	0.000474	CbGpPWpGaD
Glycine—ALAS2—Metabolism—PIK3CB—ovarian cancer	0.000137	0.000463	CbGpPWpGaD
Glycine—GSS—Metabolism—SLC2A1—ovarian cancer	0.000137	0.000462	CbGpPWpGaD
Glycine—AGXT2—Metabolism—ABCB1—ovarian cancer	0.000136	0.000459	CbGpPWpGaD
Glycine—BAAT—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	0.000136	0.000458	CbGpPWpGaD
Glycine—GLYAT—Metabolism—PIK3CG—ovarian cancer	0.000136	0.000458	CbGpPWpGaD
Glycine—GATM—Metabolism—PIK3CG—ovarian cancer	0.000136	0.000458	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—PIK3CG—ovarian cancer	0.000136	0.000458	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—PIK3CG—ovarian cancer	0.000136	0.000458	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—IL2—ovarian cancer	0.000135	0.000456	CbGpPWpGaD
Glycine—SHMT1—Metabolism—CYP1B1—ovarian cancer	0.000135	0.000454	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—TERT—ovarian cancer	0.000135	0.000454	CbGpPWpGaD
Glycine—GRIN2C—Neuronal System—MAPK1—ovarian cancer	0.000134	0.000453	CbGpPWpGaD
Glycine—SLC16A10—Transmembrane transport of small molecules—ABCB1—ovarian cancer	0.000134	0.000451	CbGpPWpGaD
Glycine—GRIN2A—Transmission across Chemical Synapses—MAPK1—ovarian cancer	0.000134	0.000451	CbGpPWpGaD
Glycine—AGXT2—Metabolism—TYMS—ovarian cancer	0.000134	0.000451	CbGpPWpGaD
Glycine—GSS—Metabolism—CYP1B1—ovarian cancer	0.000131	0.000443	CbGpPWpGaD
Glycine—GARS—Gene Expression—MAPK3—ovarian cancer	0.00013	0.000439	CbGpPWpGaD
Glycine—BAAT—Metabolism—PIK3CG—ovarian cancer	0.00013	0.000437	CbGpPWpGaD
Glycine—GARS—Gene Expression—MYC—ovarian cancer	0.000127	0.000427	CbGpPWpGaD
Glycine—AGXT—Metabolism—CAV1—ovarian cancer	0.000127	0.000427	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—CAV1—ovarian cancer	0.000125	0.00042	CbGpPWpGaD
Glycine—ALAS1—Metabolism—CAV1—ovarian cancer	0.000123	0.000414	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—ESR1—ovarian cancer	0.00012	0.000405	CbGpPWpGaD
Glycine—SHMT1—Metabolism—PPP2R1A—ovarian cancer	0.00012	0.000403	CbGpPWpGaD
Glycine—GATM—Metabolism—PIK3CD—ovarian cancer	0.000119	0.000402	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—PIK3CD—ovarian cancer	0.000119	0.000402	CbGpPWpGaD
Glycine—GLYAT—Metabolism—PIK3CD—ovarian cancer	0.000119	0.000402	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—PIK3CD—ovarian cancer	0.000119	0.000402	CbGpPWpGaD
Glycine—ALAS2—Metabolism—PTEN—ovarian cancer	0.000119	0.0004	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—IL6ST—ovarian cancer	0.000118	0.000398	CbGpPWpGaD
Glycine—ALAS1—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	0.000117	0.000395	CbGpPWpGaD
Glycine—GSS—Metabolism—PPP2R1A—ovarian cancer	0.000116	0.000393	CbGpPWpGaD
Glycine—AGXT—Metabolism—PIK3CG—ovarian cancer	0.000115	0.000389	CbGpPWpGaD
Glycine—BAAT—Metabolism—PIK3CD—ovarian cancer	0.000114	0.000384	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—APC—ovarian cancer	0.000114	0.000383	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—PIK3CG—ovarian cancer	0.000114	0.000383	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—NRAS—ovarian cancer	0.000114	0.000383	CbGpPWpGaD
Glycine—SHMT1—Disease—TERT—ovarian cancer	0.000113	0.000382	CbGpPWpGaD
Glycine—ALAS1—Metabolism—PIK3CG—ovarian cancer	0.000112	0.000377	CbGpPWpGaD
Glycine—SHMT1—Metabolism—ABCB1—ovarian cancer	0.000111	0.000374	CbGpPWpGaD
Glycine—SHMT1—Metabolism—TYMS—ovarian cancer	0.000109	0.000368	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—MAPK3—ovarian cancer	0.000109	0.000367	CbGpPWpGaD
Glycine—GSS—Metabolism—ABCB1—ovarian cancer	0.000108	0.000365	CbGpPWpGaD
Glycine—AGXT2—Metabolism—CAV1—ovarian cancer	0.000108	0.000363	CbGpPWpGaD
Glycine—GRIN2C—Neuronal System—HRAS—ovarian cancer	0.000108	0.000363	CbGpPWpGaD
Glycine—GRIN2A—Transmission across Chemical Synapses—HRAS—ovarian cancer	0.000107	0.000362	CbGpPWpGaD
Glycine—GSS—Metabolism—TYMS—ovarian cancer	0.000106	0.000358	CbGpPWpGaD
Glycine—SHMT1—Disease—CAV1—ovarian cancer	0.000105	0.000354	CbGpPWpGaD
Glycine—GATM—Metabolism—PIK3CB—ovarian cancer	0.000104	0.000351	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—PIK3CB—ovarian cancer	0.000104	0.000351	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—PIK3CB—ovarian cancer	0.000104	0.000351	CbGpPWpGaD
Glycine—GLYAT—Metabolism—PIK3CB—ovarian cancer	0.000104	0.000351	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—MAPK1—ovarian cancer	0.000103	0.000349	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—EGFR—ovarian cancer	0.000103	0.000349	CbGpPWpGaD
Glycine—GRIN2A—Neuronal System—MAPK1—ovarian cancer	0.000102	0.000345	CbGpPWpGaD
Glycine—AGXT—Metabolism—PIK3CD—ovarian cancer	0.000101	0.000342	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—PIK3CD—ovarian cancer	9.98e-05	0.000336	CbGpPWpGaD
Glycine—SHMT1—Disease—IL6ST—ovarian cancer	9.94e-05	0.000335	CbGpPWpGaD
Glycine—BAAT—Metabolism—PIK3CB—ovarian cancer	9.92e-05	0.000335	CbGpPWpGaD
Glycine—GPR18—GPCR downstream signaling—PIK3CA—ovarian cancer	9.88e-05	0.000333	CbGpPWpGaD
Glycine—ALAS1—Metabolism—PIK3CD—ovarian cancer	9.83e-05	0.000331	CbGpPWpGaD
Glycine—AGXT2—Metabolism—PIK3CG—ovarian cancer	9.82e-05	0.000331	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—KRAS—ovarian cancer	9.77e-05	0.000329	CbGpPWpGaD
Glycine—SHMT1—Disease—APC—ovarian cancer	9.55e-05	0.000322	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—PTEN—ovarian cancer	8.99e-05	0.000303	CbGpPWpGaD
Glycine—GATM—Metabolism—PTEN—ovarian cancer	8.99e-05	0.000303	CbGpPWpGaD
Glycine—GLYAT—Metabolism—PTEN—ovarian cancer	8.99e-05	0.000303	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—PTEN—ovarian cancer	8.99e-05	0.000303	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—PIK3CA—ovarian cancer	8.98e-05	0.000303	CbGpPWpGaD
Glycine—AGXT—Metabolism—PIK3CB—ovarian cancer	8.85e-05	0.000298	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—ERBB2—ovarian cancer	8.81e-05	0.000297	CbGpPWpGaD
Glycine—GARS—Gene Expression—AKT1—ovarian cancer	8.79e-05	0.000296	CbGpPWpGaD
Glycine—SHMT1—Metabolism—CAV1—ovarian cancer	8.78e-05	0.000296	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—PIK3CB—ovarian cancer	8.7e-05	0.000293	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—MTOR—ovarian cancer	8.7e-05	0.000293	CbGpPWpGaD
Glycine—AGXT2—Metabolism—PIK3CD—ovarian cancer	8.63e-05	0.000291	CbGpPWpGaD
Glycine—BAAT—Metabolism—PTEN—ovarian cancer	8.58e-05	0.000289	CbGpPWpGaD
Glycine—ALAS1—Metabolism—PIK3CB—ovarian cancer	8.57e-05	0.000289	CbGpPWpGaD
Glycine—GSS—Metabolism—CAV1—ovarian cancer	8.56e-05	0.000289	CbGpPWpGaD
Glycine—SHMT1—Disease—PIK3CD—ovarian cancer	8.4e-05	0.000283	CbGpPWpGaD
Glycine—ALAS2—Metabolism—PIK3CA—ovarian cancer	8.37e-05	0.000282	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—CXCL8—ovarian cancer	8.36e-05	0.000282	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—HRAS—ovarian cancer	8.3e-05	0.00028	CbGpPWpGaD
Glycine—GRIN2A—Neuronal System—HRAS—ovarian cancer	8.23e-05	0.000277	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—CDKN1B—ovarian cancer	8.16e-05	0.000275	CbGpPWpGaD
Glycine—GPR18—GPCR downstream signaling—AKT1—ovarian cancer	8.07e-05	0.000272	CbGpPWpGaD
Glycine—SHMT1—Metabolism—PIK3CG—ovarian cancer	8e-05	0.00027	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—CASP3—ovarian cancer	8e-05	0.00027	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—IL2—ovarian cancer	7.99e-05	0.000269	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—IL6—ovarian cancer	7.95e-05	0.000268	CbGpPWpGaD
Glycine—GSS—Metabolism—PIK3CG—ovarian cancer	7.8e-05	0.000263	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—CCND1—ovarian cancer	7.79e-05	0.000263	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—CTNNB1—ovarian cancer	7.71e-05	0.00026	CbGpPWpGaD
Glycine—AGXT—Metabolism—PTEN—ovarian cancer	7.64e-05	0.000258	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—MMP9—ovarian cancer	7.56e-05	0.000255	CbGpPWpGaD
Glycine—AGXT2—Metabolism—PIK3CB—ovarian cancer	7.52e-05	0.000254	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—PTEN—ovarian cancer	7.52e-05	0.000253	CbGpPWpGaD
Glycine—SHMT1—Disease—ERBB2—ovarian cancer	7.42e-05	0.00025	CbGpPWpGaD
Glycine—ALAS1—Metabolism—PTEN—ovarian cancer	7.4e-05	0.00025	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—AKT1—ovarian cancer	7.33e-05	0.000247	CbGpPWpGaD
Glycine—SHMT1—Disease—MTOR—ovarian cancer	7.32e-05	0.000247	CbGpPWpGaD
Glycine—SHMT1—Disease—PIK3CB—ovarian cancer	7.32e-05	0.000247	CbGpPWpGaD
Glycine—SHMT1—Metabolism—PIK3CD—ovarian cancer	7.03e-05	0.000237	CbGpPWpGaD
Glycine—SHMT1—Disease—CDKN1B—ovarian cancer	6.87e-05	0.000232	CbGpPWpGaD
Glycine—GSS—Metabolism—PIK3CD—ovarian cancer	6.85e-05	0.000231	CbGpPWpGaD
Glycine—ALAS2—Metabolism—AKT1—ovarian cancer	6.84e-05	0.00023	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—VEGFA—ovarian cancer	6.79e-05	0.000229	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—STAT3—ovarian cancer	6.72e-05	0.000227	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—NRAS—ovarian cancer	6.71e-05	0.000226	CbGpPWpGaD
Glycine—AGXT2—Metabolism—PTEN—ovarian cancer	6.5e-05	0.000219	CbGpPWpGaD
Glycine—SHMT1—Disease—CTNNB1—ovarian cancer	6.49e-05	0.000219	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—MAPK3—ovarian cancer	6.42e-05	0.000217	CbGpPWpGaD
Glycine—GLYAT—Metabolism—PIK3CA—ovarian cancer	6.34e-05	0.000214	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—PIK3CA—ovarian cancer	6.34e-05	0.000214	CbGpPWpGaD
Glycine—GATM—Metabolism—PIK3CA—ovarian cancer	6.34e-05	0.000214	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—PIK3CA—ovarian cancer	6.34e-05	0.000214	CbGpPWpGaD
Glycine—SHMT1—Disease—PTEN—ovarian cancer	6.33e-05	0.000213	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—MYC—ovarian cancer	6.25e-05	0.000211	CbGpPWpGaD
Glycine—SHMT1—Metabolism—PIK3CB—ovarian cancer	6.13e-05	0.000207	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—MAPK1—ovarian cancer	6.11e-05	0.000206	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—EGFR—ovarian cancer	6.11e-05	0.000206	CbGpPWpGaD
Glycine—BAAT—Metabolism—PIK3CA—ovarian cancer	6.05e-05	0.000204	CbGpPWpGaD
Glycine—GSS—Metabolism—PIK3CB—ovarian cancer	5.97e-05	0.000201	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—KRAS—ovarian cancer	5.77e-05	0.000195	CbGpPWpGaD
Glycine—SHMT1—Disease—STAT3—ovarian cancer	5.66e-05	0.000191	CbGpPWpGaD
Glycine—SHMT1—Disease—NRAS—ovarian cancer	5.64e-05	0.00019	CbGpPWpGaD
Glycine—SHMT1—Disease—MAPK3—ovarian cancer	5.41e-05	0.000182	CbGpPWpGaD
Glycine—AGXT—Metabolism—PIK3CA—ovarian cancer	5.39e-05	0.000182	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—PIK3CA—ovarian cancer	5.3e-05	0.000179	CbGpPWpGaD
Glycine—SHMT1—Metabolism—PTEN—ovarian cancer	5.3e-05	0.000179	CbGpPWpGaD
Glycine—SHMT1—Disease—MYC—ovarian cancer	5.26e-05	0.000177	CbGpPWpGaD
Glycine—ALAS1—Metabolism—PIK3CA—ovarian cancer	5.22e-05	0.000176	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—AKT1—ovarian cancer	5.18e-05	0.000175	CbGpPWpGaD
Glycine—GLYAT—Metabolism—AKT1—ovarian cancer	5.18e-05	0.000175	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—AKT1—ovarian cancer	5.18e-05	0.000175	CbGpPWpGaD
Glycine—GATM—Metabolism—AKT1—ovarian cancer	5.18e-05	0.000175	CbGpPWpGaD
Glycine—GSS—Metabolism—PTEN—ovarian cancer	5.16e-05	0.000174	CbGpPWpGaD
Glycine—SHMT1—Disease—MAPK1—ovarian cancer	5.14e-05	0.000173	CbGpPWpGaD
Glycine—SHMT1—Disease—EGFR—ovarian cancer	5.14e-05	0.000173	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—TP53—ovarian cancer	5.13e-05	0.000173	CbGpPWpGaD
Glycine—BAAT—Metabolism—AKT1—ovarian cancer	4.94e-05	0.000167	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—HRAS—ovarian cancer	4.91e-05	0.000165	CbGpPWpGaD
Glycine—SHMT1—Disease—KRAS—ovarian cancer	4.86e-05	0.000164	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—IL6—ovarian cancer	4.7e-05	0.000158	CbGpPWpGaD
Glycine—AGXT2—Metabolism—PIK3CA—ovarian cancer	4.58e-05	0.000155	CbGpPWpGaD
Glycine—SHMT1—Disease—PIK3CA—ovarian cancer	4.46e-05	0.00015	CbGpPWpGaD
Glycine—AGXT—Metabolism—AKT1—ovarian cancer	4.4e-05	0.000149	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—AKT1—ovarian cancer	4.33e-05	0.000146	CbGpPWpGaD
Glycine—ALAS1—Metabolism—AKT1—ovarian cancer	4.27e-05	0.000144	CbGpPWpGaD
Glycine—SHMT1—Disease—HRAS—ovarian cancer	4.13e-05	0.000139	CbGpPWpGaD
Glycine—SHMT1—Disease—IL6—ovarian cancer	3.95e-05	0.000133	CbGpPWpGaD
Glycine—AGXT2—Metabolism—AKT1—ovarian cancer	3.75e-05	0.000126	CbGpPWpGaD
Glycine—SHMT1—Metabolism—PIK3CA—ovarian cancer	3.74e-05	0.000126	CbGpPWpGaD
Glycine—SHMT1—Disease—AKT1—ovarian cancer	3.65e-05	0.000123	CbGpPWpGaD
Glycine—GSS—Metabolism—PIK3CA—ovarian cancer	3.64e-05	0.000123	CbGpPWpGaD
Glycine—SHMT1—Metabolism—AKT1—ovarian cancer	3.05e-05	0.000103	CbGpPWpGaD
Glycine—GSS—Metabolism—AKT1—ovarian cancer	2.98e-05	0.0001	CbGpPWpGaD
